| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/13/1992 | EP0214299B1 Preparation of 5-fluoro-2'-deoxyuridine esters for intraarterial administration |
| 05/13/1992 | EP0195015B1 Pharmaceutical composition for combination therapy of hormone dependent cancers |
| 05/13/1992 | CN1061026A Process for producing 6-( 3-dimethylaminopropionyl ) forskolin |
| 05/13/1992 | CN1060964A Prearation method of bot harm medicine |
| 05/13/1992 | CN1060962A Composition containing ephedrine base and alkyl salicylate for delivery of ephedrine hase in vapor form |
| 05/13/1992 | CN1060948A Nutritional composition and process for its production |
| 05/13/1992 | CN1016607B Method for preparing crystalline cefadroxil monoltyrate |
| 05/12/1992 | US5112988 Intermediates for Substance P Antagonists |
| 05/12/1992 | US5112986 Chemical intermediates for analgesics |
| 05/12/1992 | US5112972 Cardiovascular disorders as hypotensive agents, angina pectoris |
| 05/12/1992 | US5112967 Process for synthesizing antibacterial cephalosporin compounds |
| 05/12/1992 | US5112963 Modified oligonucleotides |
| 05/12/1992 | US5112922 Polystyrene anion exchange polymers |
| 05/12/1992 | US5112872 Antispasmodic agent |
| 05/12/1992 | US5112870 Enhancing activity of protective ocular enzymes to prevent cataracts |
| 05/12/1992 | US5112867 Triphenylmethane derivatives |
| 05/12/1992 | US5112866 Sulfonylfluorides as intermediates, also useful in treatment of bone disorders, antisecretory, antiulcer |
| 05/12/1992 | US5112865 Dialysis solution without glucose |
| 05/12/1992 | US5112863 Antipsychotic drug |
| 05/12/1992 | US5112861 Method of treating parkinson's disease using pentanedione derivatives |
| 05/12/1992 | US5112858 Antitumor agent |
| 05/12/1992 | US5112857 Hmg-coa reductase inhibitor metabolites |
| 05/12/1992 | US5112856 Leukotriene inhibitors |
| 05/12/1992 | US5112854 Macrolide compounds |
| 05/12/1992 | US5112850 Drug for treatment of gastric and duodenal peptic ulcer disease |
| 05/12/1992 | US5112848 Furan and pyrrole containing lipoxygenase inhibiting compounds |
| 05/12/1992 | US5112844 Micelles |
| 05/12/1992 | US5112842 Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole |
| 05/12/1992 | US5112841 Imidazole derivatives and antiepileptics comprising said imidazole derivatives as effective ingredients |
| 05/12/1992 | US5112839 Treatment of Cardiac Insufficiency, Angina, Arrhythmia, Hypertension |
| 05/12/1992 | US5112838 Treatment of schizophrenia |
| 05/12/1992 | US5112837 Inhibitors of thymidylate synthetase enzyme |
| 05/12/1992 | US5112836 Autoimmune diseases, antirheumatic agents and metabolic bone diseases |
| 05/12/1992 | US5112834 Antisecretory and antiulcer |
| 05/12/1992 | US5112827 Purine derivatives, pentoxifylline, anticholesterol, arterial antideposit agents |
| 05/12/1992 | US5112826 Cardiovascular disorders |
| 05/12/1992 | US5112822 Gastrointestinal disorders and glaucoma treatment |
| 05/12/1992 | US5112820 Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof |
| 05/12/1992 | US5112819 Anticholesterol and antilipemic agents |
| 05/12/1992 | US5112816 Corticorsteroid-containing ointments |
| 05/12/1992 | US5112815 9α-hydroxy-3-oxo-4,24(25)-stigmastadien-26-oic acid derivatives, a process for preparing same and pharmaceutical compositions containing same |
| 05/12/1992 | US5112814 Method of treatment of Parkinson's disease using phytic acid |
| 05/12/1992 | US5112746 Fermentation of streptomyces |
| 05/12/1992 | US5112621 Sustained release pharmaceutical composition of diltiazem |
| 05/12/1992 | US5112620 Blend of polyether and water soluble salt of maleic acid or anhydride copolymer with methyl vinyl ether with anesthetic and steroid |
| 05/12/1992 | US5112617 Method for controlling cold symptoms |
| 05/12/1992 | US5112608 Use of protease nexin-I to mediate wound healing |
| 05/12/1992 | US5112604 Oral suspension formulation |
| 05/12/1992 | US5112603 Thickening agents for aqueous systems |
| 05/12/1992 | US5112598 Vitamin a aerosol-inhalate preparations |
| 05/12/1992 | US5112596 A composition of a neuropharmaceutical or diagnostic agent, a bradykinin agonist to increase blood brain barrier permeability |
| 05/12/1992 | US5112515 Phenothrin shampoo |
| 05/12/1992 | CA1300807C Heterocyclic derivatives |
| 05/12/1992 | CA1300642C2 Eicosatetraynoic - 5,8,11,14 acid preparation process |
| 05/12/1992 | CA1300632C Acetylene amines and their use as vasodilators and antihypertensives |
| 05/12/1992 | CA1300630C 8-piperazinyl-1, 7-naphthyridine derivative |
| 05/12/1992 | CA1300627C 4-aminoaryldihydropyridine lactones, process for their preparation and their use in medicaments |
| 05/12/1992 | CA1300626C Dihydropyridine compounds, processes for their preparation and their use |
| 05/12/1992 | CA1300625C 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-[1]benzothieno [3,2-e]-1,2-thiazine-4-carboxamide-1,1-dioxides |
| 05/12/1992 | CA1300624C 2-pyrimidinyl-1-piperazine derivatives, processes for their preparation and medicaments containing them |
| 05/12/1992 | CA1300623C Process for the preparation of quinazolinone compounds |
| 05/12/1992 | CA1300622C Anti-viral compounds |
| 05/12/1992 | CA1300621C 3-substituted benzazepines |
| 05/12/1992 | CA1300620C Benzazepine derivatives |
| 05/12/1992 | CA1300619C 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use |
| 05/12/1992 | CA1300617C Mono- and diepoxide derivatives of 23-deoxy-ll-f28249 compounds |
| 05/12/1992 | CA1300616C Mono- and diepoxide derivatives of ll-f28249 compounds |
| 05/12/1992 | CA1300614C 23-imino derivatives of 23-keto compounds |
| 05/12/1992 | CA1300612C Immunotherapeutic treatment |
| 05/12/1992 | CA1300609C 13-spiro-2'-¬tetrahydrofuran|-milbemycines, process for their preparation and their use against parasites and insect pests |
| 05/12/1992 | CA1300604C Methoxymethyl compounds |
| 05/12/1992 | CA1300603C Process for the conversion of the e-isomer of 6-(substituted methylene)-2-penems into the z-isomer |
| 05/12/1992 | CA1300536C Process for antifungal fermentation product and culture |
| 05/12/1992 | CA1300510C Stabilized composition containing angiotensin converting enzyme |
| 05/12/1992 | CA1300509C Pharmaceutical compositions for relief of dysmenorrhea and/orpremenstrual syndrome and process |
| 05/12/1992 | CA1300508C Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease |
| 05/12/1992 | CA1300507C Nonsteroidal anti-inflammatory drug composition containing h _blockers, h _blockers, beta-adrenergic agonists or combinations thereof and analkalizing agent, and process for administrations |
| 05/12/1992 | CA1300506C Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives |
| 05/12/1992 | CA1300505C Amelioration or elimination of postoperative pain |
| 05/12/1992 | CA1300504C Pharmaceutical composition for treatment of cataract |
| 05/12/1992 | CA1300501C Ovulation treatment |
| 05/12/1992 | CA1300493C Radiation compatible iodine formulation |
| 05/11/1992 | WO1992008457A1 Use of thiazolo-isoindolinone derivatives as antiviral medicaments |
| 05/11/1992 | CA2095249A1 Use of thiazoloisoindolinone derivatives as antiviral medicaments |
| 05/10/1992 | WO1992008697A2 9-HALOGEN-11β-HYDROXY PROSTAGLANDIN DERIVATIVE, PROCESS FOR PRODUCING IT AND ITS USE AS A MEDICAMENT |
| 05/10/1992 | WO1992008684A1 Local anaesthetic |
| 05/10/1992 | WO1992008449A1 Procaterol-containing plaster |
| 05/10/1992 | WO1992004342A1 A novel quinolone carboxylic acid derivative |
| 05/10/1992 | CA2096027A1 Local anesthetic |
| 05/10/1992 | CA2073462A1 9-halogen-11beta-hydroxy-prostaglandin derivatives, process for their production and their use as pharmaceutical agents |
| 05/10/1992 | CA2073254A1 Procaterol-containing preparation for application to the skin |
| 05/10/1992 | CA2072883A1 Cephalosporin compounds and processes for preparation thereof |
| 05/10/1992 | CA2055189A1 Process for preparing 1-{2-¬ (5-dimethyllaminomethyl-2-furyl) -methylthio)-ethyl)-amino-1-methylamino-2-nitroethylene |
| 05/10/1992 | CA2055180A1 Aerosol composition and a process preparing same |
| 05/09/1992 | CA2055093A1 Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives, process for their production and pharmaceutical agents containing these derivatives |
| 05/09/1992 | CA2054983A1 Suspendible composition and process for preparing the same |
| 05/09/1992 | CA2054520A1 Antimanic phenoxymethylene bisphosphonate derivatives |
| 05/08/1992 | WO1992008707A1 Chelating agents |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |